Alumis Inc. Enters Material Definitive Agreement
Ticker: ALMS · Form: 8-K · Filed: Apr 21, 2025 · CIK: 1847367
| Field | Detail |
|---|---|
| Company | Alumis Inc. (ALMS) |
| Form Type | 8-K |
| Filed Date | Apr 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-event
TL;DR
Alumis Inc. just signed a big deal, filing an 8-K on 4/20/25.
AI Summary
Alumis Inc. announced on April 20, 2025, that it entered into a material definitive agreement. The company, formerly known as Esker Therapeutics, Inc., is incorporated in Delaware and headquartered in South San Francisco, California.
Why It Matters
This filing indicates a significant new contract or partnership for Alumis Inc., which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks related to the terms of the agreement, counterparty performance, and integration challenges.
Key Players & Entities
- Alumis Inc. (company) — Registrant
- Esker Therapeutics, Inc. (company) — Former company name
- April 20, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- South San Francisco, California (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Alumis Inc.?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on April 20, 2025.
When was Alumis Inc. formerly known as Esker Therapeutics, Inc.?
The date of the name change from Esker Therapeutics, Inc. to Alumis Inc. was April 27, 2023.
What is Alumis Inc.'s primary business sector?
Alumis Inc. is in the Pharmaceutical Preparations sector, with SIC code 2834.
Where are Alumis Inc.'s principal executive offices located?
Alumis Inc.'s principal executive offices are located at 280 East Grand Avenue, South San Francisco, California 94080.
What is the Commission File Number for Alumis Inc.?
The Commission File Number for Alumis Inc. is 001-42143.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2025 regarding ALUMIS INC. (ALMS).